Previous 10 | Next 10 |
BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress PR Newswire Data from Longest and Largest Hemophilia Gene Therapy ...
2024-06-05 22:43:17 ET Summary Dan Loeb's 13F portfolio value increased from $6.64B to $7.85B in Q1 2024. The top three holdings account for approximately 34% of the entire portfolio. New stakes include Alphabet Inc., Advanced Auto Parts, Cinemark Holdings, Goldman Sachs, Marv...
2024-06-04 16:00:04 ET William Pickering from Tudor Pickering issued a price target of $91.00 for BMRN on 2024-06-04 14:03:00. The adjusted price target was set to $91.00. At the time of the announcement, BMRN was trading at $78.87. The overall price target consensus is ...
2024-06-04 15:30:03 ET Bernstein analyst issues MARKET PERFORM recommendation for BMRN on June 4, 2024 02:03PM ET. The previous analyst recommendation was Market Perform. BMRN was trading at $78.865 at issue of the analyst recommendation. The overall analyst consensus : ...
2024-06-04 15:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for BMRN on June 4, 2024 02:01PM ET. The previous analyst recommendation was Overweight. BMRN was trading at $78.865 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-05-29 20:54:18 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value decreased from $27.3B to $26.9B in Q1 2024. The number of holdings in the portfolio increased from 79 to 83. The largest five individual stock positions are Visa, Workday, Amazon.com, Philip Morri...
2024-05-26 08:10:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...
2024-05-26 05:30:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 37.1% to $0.108 on volume of 436,246,446 shares Ascent Solar Technologies Inc (ASTI) rose 114.8% to $0.282249 on volume of 221,176,942 shares OneMedNet Corp (ONMD) rose 134.7% to $1.15 o...
2024-05-17 05:00:04 ET Jack Allen from Robert W. Baird issued a price target of $72.00 for BMRN on 2024-05-17 03:08:00. The adjusted price target was set to $72.00. At the time of the announcement, BMRN was trading at $76.97. The overall price target consensus is at $115...
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin Pharmaceutical Inc. Website:
2024-07-10 03:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-27 14:15:03 ET Scotiabank analyst issues UNDERPERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Underperform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-06-27 14:15:02 ET Wells Fargo analyst issues SECTOR PERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Sector Perform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus...